SCHEMBL441966

SCHEMBL441966

C=CCc1ccc(OC(C)C(=O)OC(C)c2ccccc2)c(OC)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.57
MEN1 O00255 3/20 0.57
CYP3A4 P08684 2/20 0.57
TDP1 Q9NUW8 2/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
PTGS1 P23219 2/20 0.52
ALDH1A1 P00352 6/20 0.51
PPARA Q07869 3/20 0.51
PPARG P37231 1/20 0.51
PPARD Q03181 1/20 0.51
KDM4E B2RXH2 4/20 0.48
MAPT P10636 3/20 0.48
HTT P42858 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
LMNA P02545 1/20 0.48
GAA P10253 1/20 0.48
CCR3 P51677 1/20 0.48
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
ALOX5 P09917 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyleugenol SCHEMBL441965 0.85 PTGS1 (0.62) KMT2AMEN1CYP3A4TDP1L3MBTL1
SCHEMBL19900784 0.82 ALDH1A1 (0.63) KMT2AMEN1CYP3A4TDP1L3MBTL1
SCHEMBL9404982 0.77 ALDH1A1 (0.58) KMT2AMEN1CYP3A4TDP1L3MBTL1
SCHEMBL3693447 0.77 ALDH1A1 (0.58) KMT2AMEN1CYP3A4TDP1L3MBTL1
SCHEMBL28551757 0.75 HCAR2 (0.44) KMT2AMEN1L3MBTL1ALDH1A1MAPT
SCHEMBL21414823 0.74 ALDH1A1 (0.75) KMT2AMEN1CYP3A4TDP1L3MBTL1
Methyleugenol SCHEMBL28484578 0.74 PPARA (0.81) KMT2AMEN1CYP3A4TDP1L3MBTL1
Zinc Ion SCHEMBL11765363 0.74 MEN1 (0.57) KMT2AMEN1CYP3A4TDP1L3MBTL1
SCHEMBL19900387 0.74 PTGS1 (0.72) KMT2AMEN1CYP3A4TDP1L3MBTL1
SCHEMBL873274 0.73 MEN1 (0.73) KMT2AMEN1CYP3A4TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099948-A1 Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents COLABS INT'L CORP. (US) 2024-03-28 US disclosed
US-11839674-B2 Compositions comprising silicon dioxide-based particles including one or more agents CoLabs International Corporation (US) 2023-12-12 US disclosed
US-11724134-B2 Compositions containing a cellulose derived capsule with a sunscreen active agent CoLabs International Corporation (US) 2023-08-15 US disclosed
US-11707421-B2 Compositions containing a flexible derived capsule with an active agent COLABS INT'L CORP. (US) 2023-07-25 US disclosed
US-20230113098-A1 Compositions Containing a Capsule with an Agent COLABS INT'L CORP. (US) 2023-04-13 US disclosed
US-20230087601-A1 COSMETIC COMPOSITIONS CONTAINING LOW MOLECULAR WEIGHT AMORPHOUS GRADE POLYLACTIC ACID RESIN NATUREWORKS LLC 2023-03-23 US disclosed
EP-4106881-A1 COSMETIC COMPOSITIONS CONTAINING LOW MOLECULAR WEIGHT AMORPHOUS GRADE POLYLACTIC ACID RESIN NatureWorks LLC (US) 2022-12-28 EP disclosed
EP-3813786-A1 COMPOSITIONS COMPRISING SILICON DIOXIDE-BASED PARTICLES INCLUDING ONE OR MORE AGENTS Colabs International Corporation (US) 2021-05-05 EP disclosed
US-20210045980-A1 Grip Enhancing Compositions, and Methods and Uses Thereof Collidion, Inc. (US) 2021-02-18 US disclosed
US-20190290940-A1 Compositions Containing a Cellulose Derived Capsule with a Sunscreen Active Agent CoLabs International Corporation (US) 2019-09-26 US disclosed
EP-2568954-A2 FRAGRANT FORMULATIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME Segetis, Inc. (US) 2013-03-20 EP disclosed
US-8188030-B2 Fabric softener compositions and methods of manufacture thereof SEGETIS, INC. (US) 2012-05-29 US disclosed
WO-2012037122-A2 FABRIC SOFTENER COMPOSITIONS AND METHODS OF MANUFACTURE THEREOF SEGETIS, INC. (US) 2012-03-22 WO disclosed
US-20120065113-A1 FABRIC SOFTENER COMPOSITIONS AND METHODS OF MANUFACTURE THEREOF SEGETIS, INC. (US) 2012-03-15 US disclosed
WO-2011143242-A2 FRAGRANT FORMULATIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME SEGETIS, INC. (US) 2011-11-17 WO disclosed
US-20110274643-A1 FRAGRANT FORMULATIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME SEGETIS, INC. (US) 2011-11-10 US disclosed
WO-1998041603-A1 FABRIC LAUNDRY TREATMENT COMPOSITION UNILEVER PLC (GB) 1998-09-24 WO disclosed
WO-1996009365-A1 CLEAR CONCENTRATED FABRIC SOFTENER ANSARI, RAHMAN, H. 1996-03-28 WO disclosed
US-5492636-A CONTAINING QUATERNARY AMMONIUM CHLORIDE OR IMIDAZOLINIUM SALT FABRIC SOFTENER, BUTYL CARBITOL, FRAGRANCE, WATER; CLEAR, FREE-FLOWING LIQUID QUEST INTERNATIONAL FRAGRANCES COMPANY (US) 1996-02-20 US disclosed
US-5425887-A Hydrocarbon based quaternary ammonium salt as fabric conditioner and capsule consists of emulsion of perfume and solution of water soluble natural or synthetic polymer and water LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1995-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230087601-A1 COSMETIC COMPOSITIONS CONTAINING LOW MOLECULAR WEIGHT AMORPHOUS GRADE POLYLACTIC ACID RESIN CUTA, RARA, RARG KMT2A 409/4885MEN1 2466/4885CYP3A4 4807/4885
US-11707421-B2 Compositions containing a flexible derived capsule with an active agent CUTA, LIPE, LIPA KMT2A 3272/4885MEN1 299/4885CYP3A4 3480/4885
US-11724134-B2 Compositions containing a cellulose derived capsule with a sunscreen active agent CUTA, ACMSD, TYR KMT2A 4008/4885MEN1 139/4885CYP3A4 2323/4885
US-20110274643-A1 FRAGRANT FORMULATIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME FASN, ELOVL6, ALOX5 KMT2A 284/4885MEN1 4125/4885CYP3A4 201/4885
US-20190290940-A1 Compositions Containing a Cellulose Derived Capsule with a Sunscreen Active Agent CUTA, ACMSD, TYR KMT2A 4008/4885MEN1 139/4885CYP3A4 2323/4885
US-20230113098-A1 Compositions Containing a Capsule with an Agent LIPA, CUTA, FABP4 KMT2A 3786/4885MEN1 272/4885CYP3A4 3235/4885
US-20240099948-A1 Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents MSN, LIPE, CUTA KMT2A 2603/4885MEN1 84/4885CYP3A4 3904/4885
US-20210045980-A1 Grip Enhancing Compositions, and Methods and Uses Thereof ACHE, CD68, GYS1 KMT2A 3211/4885MEN1 2747/4885CYP3A4 4722/4885
US-11839674-B2 Compositions comprising silicon dioxide-based particles including one or more agents MSN, LIPE, CUTA KMT2A 2641/4885MEN1 81/4885CYP3A4 3902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.